Dr. Keith Jeffrey Stelzer, MD, PhD

Dr. Stelzer practices at Adventist Health Columbia Gorge in The Dalles, Oregon, part of Adventist Health.

Dr. Stelzer's NPI, 1881682573, was assigned on October 7, 2005. Dr. Stelzer graduated from University of California, Geffen School of Medicine in 1989. Dr. Stelzer holds Oregon license MD22525.

Dr. Stelzer's primary practice is Adventist Health Columbia Gorge, at 1700 E 19th Street, The Dalles, OR 97058 in Wasco County. The practice phone is (541) 296-1111.

Dr. Stelzer's primary practice is Adventist Health Columbia Gorge in The Dalles, Oregon, part of Adventist Health. The medical group on file is Adventist Health Columbia Gorge.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stelzer practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Stelzer's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Stelzer's licenses on file in 2 states: Oregon and Washington.

CMS data shows 436 Medicare services from Dr. Stelzer across 9 procedure codes in 2024, for 105 Medicare patients. Medicare paid $23,549 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 105 Medicare patients who saw Dr. Stelzer in 2024. The largest group is 65 to 74, with 52 patients. 74% of them have cancer, and 66% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stelzer's median patient age at 70, with 58% women.

In 2024, Dr. Stelzer wrote 15 Medicare Part D claims. 100% of them were for generic drugs. They cover 2 drugs, with $671 in total drug cost. In 2016, CMS named 13 claims across 1 drug.

Dr. Stelzer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Stelzer, published from 2012 to 2020. 2014 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Brain Neoplasms and Carboplatin. Dr. Stelzer has published most often in Am J Clin Oncol. Dr. Stelzer's most frequent co-authors are Geoffrey Ross Barger, MD, Mark Raymond Gilbert, MD and Paul D. Brown, MD.

Dmand AI links Dr. Stelzer to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Lung Neoplasms and Breast Diseases.

CMS Open Payments shows 12 general payments to Dr. Stelzer from 9 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $103.

Dr. Stelzer graduated from University of California, Geffen School of Medicine in 1989.